By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Medical Developments International Limited

Medical Developments International Limited (MDDVF)

OTC Market Data in USD, Fundamentals in AUD
$0.32
$0.00
0.00%
Last Update: 2 Sept 2025, 00:00
$36.12M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.25 - $0.51
52 Week Range

MDDVF Stock Price Chart

Explore Medical Developments International Limited interactive price chart. Choose custom timeframes to analyze MDDVF price movements and trends.

MDDVF Company Profile

Discover essential business fundamentals and corporate details for Medical Developments International Limited (MDDVF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

21 Jan 2020

Employees

CEO

Brent MacGregor

Description

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.

MDDVF Financial Timeline

Browse a chronological timeline of Medical Developments International Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 Feb 2026

Earnings released on 20 Aug 2025

EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $12.56M , beating expectations by +0.53%.

Earnings released on 26 Feb 2025

Earnings released on 19 Feb 2025

EPS came in at $0.00 surpassing the estimated -$0.01 by +114.99%, while revenue for the quarter reached $12.37M , missing expectations by -1.05%.

Earnings released on 25 Aug 2024

EPS came in at -$0.23 falling short of the estimated -$0.14 by -67.09%, while revenue for the quarter reached $12.05M , missing expectations by -0.16%.

Earnings released on 28 Apr 2024

Earnings released on 28 Feb 2024

EPS came in at -$0.08 falling short of the estimated -$0.03 by -216.92%, while revenue for the quarter reached $10.27M , missing expectations by -24.59%.

Earnings released on 30 Dec 2023

EPS came in at -$0.08 , while revenue for the quarter reached $10.27M .

Earnings released on 30 Aug 2023

EPS came in at -$0.07 , while revenue for the quarter reached $12.45M , beating expectations by +16.88%.

Earnings released on 30 Jun 2023

EPS came in at -$0.06 , while revenue for the quarter reached $12.23M .

Earnings released on 23 Feb 2023

EPS came in at $0.02 , while revenue for the quarter reached $9.49M .

Stock split effective on 9 Feb 2023

Shares were split 63 : 62 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Dec 2022

EPS came in at $0.02 , while revenue for the quarter reached $9.52M .

Earnings released on 3 Aug 2022

Earnings released on 30 Jun 2022

EPS came in at -$0.05 , while revenue for the quarter reached $8.78M .

Earnings released on 24 Feb 2022

EPS came in at -$0.07 , while revenue for the quarter reached $6.96M , missing expectations by -11.14%.

Earnings released on 31 Dec 2021

EPS came in at -$0.07 , while revenue for the quarter reached $6.96M .

Earnings released on 24 Aug 2021

EPS came in at -$0.04 , while revenue for the quarter reached $9.53M , missing expectations by -5.22%.

Earnings released on 30 Jun 2021

EPS came in at -$0.12 , while revenue for the quarter reached $9.53M .

Earnings released on 25 Feb 2021

EPS came in at -$0.01 , while revenue for the quarter reached $9.70M , missing expectations by -2.53%.

Earnings released on 31 Dec 2020

EPS came in at -$0.01 , while revenue for the quarter reached $9.64M .

MDDVF Stock Performance

Access detailed MDDVF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run